← Back to Search

Behavioral Intervention

Intervention for Acute Lymphoblastic Leukemia (HEAL-Tx:ToC Trial)

N/A

Recruiting

Led By Sharad Wadhwani, MD, MPH

Research Sponsored by University of California, San Francisco

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patient has received a liver transplant >1 year ago

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 180 days

Awards & highlights

HEAL-Tx:ToC Trial Summary

"This trial is testing a new program called the Health Advocate for Liver Transplant (HEAL-Tx) Transition of Care Pilot. The program aims to help adolescents transition their care to adult transplant teams by

Who is the study for?

This trial is for adolescents and young adults who have had a liver transplant and are transitioning their care to adult transplant teams. It's designed to see if having a Health Advocate helps with this process.Check my eligibility

What is being tested?

The HEAL-Tx pilot tests the integration of a Health Advocate into the transplant team. This role includes coordinating treatment, helping with finances like taxi vouchers, and linking patients to community resources.See study design

What are the potential side effects?

Since this trial involves non-medical intervention by introducing a Health Advocate rather than medication or surgery, there are no direct medical side effects associated with it.

HEAL-Tx:ToC Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I had a liver transplant more than a year ago.

HEAL-Tx:ToC Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 180 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~180 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 180 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Changes in patient experience

Secondary outcome measures

A qualitative assessment of patient and healthcare provider satisfaction with the Health Advocate intervention.

Change in medication adherence using MLVI

The quality of health advocate interactions with the participants, healthcare team, and community-based resources.

HEAL-Tx:ToC Trial Design

1Treatment groups

Experimental Treatment

Group I: InterventionExperimental Treatment1 Intervention

This is a single arm pilot intervention.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Health Advocate

2017

N/A

~40

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

American Society of TransplantationUNKNOWN

1 Previous Clinical Trials

24 Total Patients Enrolled

University of California, San FranciscoLead Sponsor

2,512 Previous Clinical Trials

15,243,891 Total Patients Enrolled

Sharad Wadhwani, MD, MPHPrincipal InvestigatorUniversity of California, San Francisco

2 Previous Clinical Trials

510 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals older than 70 years of age being enrolled in this research study?

"To be considered for enrollment in this study, individuals must be between 18 and 25 years old."

Answered by AI

What is the current number of individuals who are being enrolled in this clinical investigation?

"Indeed, information on clinicaltrials.gov confirms that this specific medical investigation is actively seeking suitable participants. The study was initially disclosed on March 3rd, 2024 and last revised on April 23rd, 2024. There is a need for approximately 20 individuals to partake in the trial across two designated sites."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant Recipients

2024. "HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant Recipients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06386198.

All > Liver Transplant > Paid Studies San Francisco